Calcium channel blocker use and mortality among patients with end-stage renal disease
- 1 June 2002
- journal article
- Published by Elsevier in Kidney International
- Vol. 61 (6) , 2157-2164
- https://doi.org/10.1046/j.1523-1755.2002.00355.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Nitric Oxide Metabolism in Erythropoietin-Induced HypertensionHypertension, 1998
- Nifedipine reverses the abnormalities in [Ca2+]i and proliferation of B cells from dialysis patientsKidney International, 1996
- Parathyroid hormone co-stimulation of hepatocyte proliferation is sensitive to protein kinase A and calcium channel inhibitorsBioscience Reports, 1996
- Verapamil reverses abnormal [Ca2+]i and carbohydrate metabolism of PMNL of dialysis patientsKidney International, 1995
- Down-regulation of PTH-PTHrP receptor of heart in CRF: Role of [Ca2+]iKidney International, 1995
- Altered cytosolic calcium homeostasis in rat cardiac myocytes in CRFKidney International, 1994
- Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failureKidney International, 1993
- Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertensionThe American Journal of Cardiology, 1991
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- Left Ventricular Hypertrophy in End-Stage Renal DiseaseNephron, 1988